Towards a Vaccine against Plasmodium vivax Malaria | PLOS Medicine Skip to main content
Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues Collections …

Plasmodium vivax Duffy Binding Protein (PvDBP) is the most promising vaccine candidate
for P. vivax malaria. The polymorphic nature of PvDBP induces strain-specific immune …

Background The Plasmodium vivax Duffy Binding Protein (PvDBP) is a key target of
naturally acquired immunity. However, region II of PvDBP, which contains the receptor …

Selected PvDBP-derived synthetic peptides were tested in competition assays with HLA
molecules in order to identify and evaluate their binding to a wide range of MHC class II …

The most widespread form of malaria is caused by Plasmodium vivax. To replicate, this
parasite must invade immature red blood cells through a process requiring interaction of the …

The invasion of reticulocytes by Plasmodium vivax merozoites is dependent on the
interaction of the Plasmodium vivax Duffy Binding Protein (PvDBP) with the Duffy antigen …

The receptor-binding domain of Plasmodium vivax Duffy-binding protein, region II (PvRII), is
an attractive candidate for a vaccine against P. vivax malaria. Here, we have studied the …

Invasion of human erythrocytes by Plasmodium vivax requires interaction between Duffy
binding protein (PvDBP) and the Duffy blood group antigen. The receptor-binding domain of …

The Plasmodium vivax Duffy binding protein (DBP) is essential during merozoite invasion
into human erythrocytes. Because of its biological importance, the DBP is also seen to have …

Malaria merozoites require the presence of specific surface receptors on the red blood cell
for invasion. Plasmodium vivax, requires the Duffy blood group antigen as an obligate …